5% stakes
Avoro Capital Advisors
Institution
- 5% stake reports
- 19
- 5% stake stocks
- 12
- Latest report
- 26/08/14
5% stake reports
| Stock | ||
|---|---|---|
| Hemab Therapeutics Holdings COAG08/14 | 7.06%3,298,236 sh | First report |
| Arrowhead Pharmaceuticals ARWR08/14 | 9.64%13,823,383 sh | +1.3pp |
| Avalo Therapeutics AVTX08/14 | 4.44%2,333,333 sh | −1.3pp |
| Scribe Therapeutics SCTX07/30 | 16.37%3,088,888 sh | First report |
| Damora Therapeutics DMRA05/15 | 6.27%3,783,000 sh | First report |
| Avalo Therapeutics AVTX05/15 | 5.75%1,410,000 sh | First report |
| Whitehawk Therapeutics WHWK05/14 | 19.99%18,292,675 sh | +0.0pp |
| uniQure QURE02/17 | 9.87%6,150,000 sh | +3.3pp |
| Celcuity CELC02/17 | 6.72%3,111,111 sh | First report |
| Definium Therapeutics DFTX02/17 | 5.08%5,000,000 sh | First report |
| Monte Rosa Therapeutics GLUE25/11/14 | 0%0 sh | −6.1pp |
| MoonLake Immunotherapeutics MLTX25/11/14 | 3.15%2,000,000 sh | −3.4pp |
| Structure Therapeutics GPCR25/11/14 | 9.38%16,216,665 sh | First report |
| Monte Rosa Therapeutics GLUE25/08/14 | 6.1%3,725,000 sh | −1.0pp |
| Arrowhead Pharmaceuticals ARWR25/08/14 | 8.3%11,517,441 sh | −1.3pp |
| uniQure QURE25/08/14 | 6.6%3,625,000 sh | First report |
| MoonLake Immunotherapeutics MLTX25/08/14 | 6.5%4,150,000 sh | First report |
| Whitehawk Therapeutics WHWK25/03/04 | 19.99%11,914,961 sh | +5.5pp |
| Whitehawk Therapeutics WHWK24/12/23 | 14.5%3,581,961 sh | No earlier report |
